TW200616649A - Partial and full agonists of A1 adenosine receptors - Google Patents
Partial and full agonists of A1 adenosine receptorsInfo
- Publication number
- TW200616649A TW200616649A TW094123377A TW94123377A TW200616649A TW 200616649 A TW200616649 A TW 200616649A TW 094123377 A TW094123377 A TW 094123377A TW 94123377 A TW94123377 A TW 94123377A TW 200616649 A TW200616649 A TW 200616649A
- Authority
- TW
- Taiwan
- Prior art keywords
- partial
- adenosine receptors
- full agonists
- full
- angina
- Prior art date
Links
- 101150007969 ADORA1 gene Proteins 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010003662 Atrial flutter Diseases 0.000 abstract 1
- 208000001871 Tachycardia Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000003379 purinergic P1 receptor agonist Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000006794 tachycardia Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58710004P | 2004-07-12 | 2004-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200616649A true TW200616649A (en) | 2006-06-01 |
Family
ID=34973127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094123377A TW200616649A (en) | 2004-07-12 | 2005-07-11 | Partial and full agonists of A1 adenosine receptors |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7271157B2 (zh) |
| EP (1) | EP1768991A1 (zh) |
| JP (1) | JP2008505967A (zh) |
| CN (1) | CN1980946A (zh) |
| CA (1) | CA2573682A1 (zh) |
| TW (1) | TW200616649A (zh) |
| WO (1) | WO2006017052A1 (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7713946B2 (en) | 2002-07-11 | 2010-05-11 | Cv Therapeutics, Inc. | Partial and full agonists A1 adenosine receptors |
| US7157440B2 (en) * | 2001-07-13 | 2007-01-02 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| US7265111B2 (en) * | 2002-06-27 | 2007-09-04 | Sanofi-Aventis Deutschland Gmbh | Adenosine analogues and their use as pharmaceutical agents |
| US7300923B2 (en) * | 2004-08-30 | 2007-11-27 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| KR100799116B1 (ko) * | 2006-09-26 | 2008-01-29 | 건국대학교 산학협력단 | 코디세핀을 함유하는 비만 치료 및 예방제용 약학 조성물 |
| LT2523669T (lt) | 2010-01-11 | 2017-04-25 | Inotek Pharmaceuticals Corporation | Akispūdžio mažinimo būdas, derinys ir rinkinys |
| WO2011119969A1 (en) | 2010-03-26 | 2011-09-29 | Inotek Pharmaceuticals Corporation | Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
| EP2552932A4 (en) * | 2010-03-26 | 2013-08-21 | Inotek Pharmaceuticals Corp | ADENOSINE COMPOUNDS AND USE THEREOF |
| RS56150B1 (sr) | 2012-01-26 | 2017-11-30 | Inotek Pharmaceuticals Corp | Anhidrovani polimorfi (2r,3s,4r,5r)-5-(6-(ciklopentilamino)-9h-purin-9-yl)-3,4-dihidroksitetrahidrofuran-2-yl)} metil-nitrata i postupak njegove pripreme |
| KR20150139501A (ko) | 2013-03-15 | 2015-12-11 | 이노텍 파마슈티컬스 코포레이션 | 안과용 제형 |
| CN113082020A (zh) * | 2021-04-08 | 2021-07-09 | 徐州医科大学 | 一种腺苷受体激动剂的增强剂及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040044225A1 (en) * | 2001-06-01 | 2004-03-04 | James Kanter | Chiral and achiral synthesis of 2-acyl substituted chromanes and their derivatives |
| US6946449B2 (en) | 2001-07-13 | 2005-09-20 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| US7157440B2 (en) | 2001-07-13 | 2007-01-02 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| WO2003070739A1 (en) * | 2002-02-19 | 2003-08-28 | Cv Therapeutics, Inc. | Partial and full agonists of a1 adenosine receptors |
| EP1494685B1 (en) | 2002-04-18 | 2008-12-31 | Cv Therapeutics, Inc. | Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker |
-
2005
- 2005-06-30 JP JP2007521493A patent/JP2008505967A/ja active Pending
- 2005-06-30 WO PCT/US2005/023628 patent/WO2006017052A1/en not_active Application Discontinuation
- 2005-06-30 US US11/173,416 patent/US7271157B2/en not_active Expired - Fee Related
- 2005-06-30 EP EP05769075A patent/EP1768991A1/en not_active Withdrawn
- 2005-06-30 CN CNA200580022919XA patent/CN1980946A/zh active Pending
- 2005-06-30 CA CA002573682A patent/CA2573682A1/en not_active Abandoned
- 2005-07-11 TW TW094123377A patent/TW200616649A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060009417A1 (en) | 2006-01-12 |
| EP1768991A1 (en) | 2007-04-04 |
| US7271157B2 (en) | 2007-09-18 |
| JP2008505967A (ja) | 2008-02-28 |
| CA2573682A1 (en) | 2006-02-16 |
| WO2006017052A1 (en) | 2006-02-16 |
| CN1980946A (zh) | 2007-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200616649A (en) | Partial and full agonists of A1 adenosine receptors | |
| NO20075809L (no) | DNA-PK inhibitorer | |
| NO20063501L (no) | Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese | |
| TW200637550A (en) | Thiazole-4-carboxamide derivatives as mGluR5 antagonists | |
| NZ591142A (en) | Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | |
| SG170767A1 (en) | Modified lysine-mimetic compounds | |
| PE20060527A1 (es) | COMPUESTOS DE CARBONILO COMO INHIBIDORES DEL FACTOR Xa | |
| WO2006100635A3 (en) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
| DE602006006170D1 (de) | Phenylacetylenderivate mit affinität zum mglur5-rezeptor | |
| RU2007110026A (ru) | ПОЛИМОРФНЫЕ И АМОРФНАЯ ФОРМЫ ФОСФАТНОЙ СОЛИ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5-ТЕТРАГИДРО-6Н-АЗЕПИНО[5.4.3-cd]ИНДОЛ-6-ОНА | |
| CR7691A (es) | Nuevo procedimiento de sintesis de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable | |
| CY1110934T1 (el) | (1s,5s)-3-(5,6-διχλωροπυριδιν-3-υλ)-3,6-διαζαδικυκλο[3.2.0]επτανιο βενζολοσουλφονικο | |
| WO2007047646A3 (en) | Substituted dihydro-isoindolones useful in treating kinase disorders | |
| NO20071242L (no) | Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer | |
| UA93531C2 (en) | Novel hydrogen sulfate salt | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| NO20073678L (no) | Nye fremgangsmater for fremstilling av benzofuran | |
| NO20081206L (no) | Isoquinolines derivatives as IGF -1R inhibitors | |
| NO20081621L (no) | Tetrahydrokinoliner, syntese og intermediater | |
| EA200702612A1 (ru) | Соединения бензимидазолкарбоксамида в качестве агонистов рецепторов 5-нт | |
| NO20090382L (no) | Basiske bisazoforbindelser | |
| HK1115500A1 (en) | Isoquinolines as igf-1r inhibitors | |
| NO20080165L (no) | Alfa-(aryl-OR heteroaryl-metyl)-beta piperidinopropanamidforbindelser som ORL1-receptorantagonister | |
| SI1893589T1 (sl) | Substituirani N-benzo(d)izoksazol-3-il-aminski derivati kot inhibitorji mGluR5, serotonin-(5-HT) in noradrenalinskih receptorjev in njihova uporaba za pripravo zdravil | |
| SG10201902903RA (en) | Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine |